HIGHLIGHTS
- who: Multiple Sclerosis and colleagues from the (UNIVERSITY) have published the article: Journal of Health Economics and Outcomes Research, in the Journal: (JOURNAL) of January/12,/2022
- what: Using the same database as Burks et al this study evaluated the effects of persistence and adherence on all-cause and MS-related non-DMT costs over 12 months and 24 months of DMT use. For this study, PDC was calculated as the proportion of days covered by supply of the index DMT out of 12 or 24 months post-index, depending on the analysis (365 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.